Targeting a methioninase-containing fusion protein to breast cancer urokinase receptors inhibits growth and migration.
Targeting a methioninase-containing fusion protein to breast cancer urokinase receptors inhibits growth and migration. Anticancer Res. 2006 May-Jun; 26(3A):1745-51.